vs

Side-by-side financial comparison of Orchid Island Capital, Inc. (ORC) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $38.5M, roughly 1.1× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -17.2%, a 286.0% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 85.7%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 54.9%).

Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

ORC vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.1× larger
STIM
$41.8M
$38.5M
ORC
Growing faster (revenue YoY)
ORC
ORC
+286.9% gap
ORC
372.6%
85.7%
STIM
Higher net margin
ORC
ORC
286.0% more per $
ORC
268.7%
-17.2%
STIM
Faster 2-yr revenue CAGR
ORC
ORC
Annualised
ORC
301.6%
54.9%
STIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ORC
ORC
STIM
STIM
Revenue
$38.5M
$41.8M
Net Profit
$103.4M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
268.7%
-17.2%
Revenue YoY
372.6%
85.7%
Net Profit YoY
1764.9%
43.2%
EPS (diluted)
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORC
ORC
STIM
STIM
Q4 25
$38.5M
$41.8M
Q3 25
$26.9M
$37.3M
Q2 25
$23.2M
$38.1M
Q1 25
$19.7M
$32.0M
Q4 24
$22.5M
Q3 24
$340.0K
$18.5M
Q2 24
$-697.0K
$16.4M
Q1 24
$-2.5M
$17.4M
Net Profit
ORC
ORC
STIM
STIM
Q4 25
$103.4M
$-7.2M
Q3 25
$72.1M
$-9.0M
Q2 25
$-33.6M
$-10.1M
Q1 25
$17.1M
$-12.7M
Q4 24
$-12.7M
Q3 24
$17.3M
$-13.3M
Q2 24
$-5.0M
$-9.8M
Q1 24
$19.8M
$-7.9M
Gross Margin
ORC
ORC
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
ORC
ORC
STIM
STIM
Q4 25
-12.1%
Q3 25
-19.6%
Q2 25
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
-51.7%
Q1 24
-39.4%
Net Margin
ORC
ORC
STIM
STIM
Q4 25
268.7%
-17.2%
Q3 25
267.8%
-24.3%
Q2 25
-145.0%
-26.6%
Q1 25
86.9%
-39.6%
Q4 24
-56.4%
Q3 24
5094.1%
-72.0%
Q2 24
714.3%
-59.8%
Q1 24
-794.2%
-45.2%
EPS (diluted)
ORC
ORC
STIM
STIM
Q4 25
$-0.10
Q3 25
$-0.13
Q2 25
$-0.15
Q1 25
$-0.21
Q4 24
$-0.34
Q3 24
$-0.44
Q2 24
$-0.33
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORC
ORC
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$665.9M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$1.4B
$22.4M
Total Assets
$11.7B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORC
ORC
STIM
STIM
Q4 25
$665.9M
$28.1M
Q3 25
$583.9M
$28.0M
Q2 25
$440.8M
$11.0M
Q1 25
$396.4M
$20.2M
Q4 24
$18.5M
Q3 24
$322.1M
$20.9M
Q2 24
$241.0M
$42.6M
Q1 24
$190.4M
$47.7M
Total Debt
ORC
ORC
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
ORC
ORC
STIM
STIM
Q4 25
$1.4B
$22.4M
Q3 25
$1.1B
$27.4M
Q2 25
$912.0M
$27.1M
Q1 25
$855.9M
$35.5M
Q4 24
$27.7M
Q3 24
$656.0M
$9.4M
Q2 24
$555.9M
$19.4M
Q1 24
$481.6M
$27.7M
Total Assets
ORC
ORC
STIM
STIM
Q4 25
$11.7B
$141.6M
Q3 25
$9.1B
$145.5M
Q2 25
$7.6B
$134.7M
Q1 25
$7.3B
$142.0M
Q4 24
$140.9M
Q3 24
$5.9B
Q2 24
$4.9B
$96.8M
Q1 24
$4.2B
$103.8M
Debt / Equity
ORC
ORC
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORC
ORC
STIM
STIM
Operating Cash FlowLast quarter
$120.4M
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORC
ORC
STIM
STIM
Q4 25
$120.4M
$908.0K
Q3 25
$28.0M
$-785.0K
Q2 25
$18.4M
$-3.5M
Q1 25
$25.8M
$-17.0M
Q4 24
$-8.6M
Q3 24
$-14.8M
$-5.4M
Q2 24
$19.3M
$-5.0M
Q1 24
$45.0M
$-12.0M
Free Cash Flow
ORC
ORC
STIM
STIM
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
Q1 24
$-12.4M
FCF Margin
ORC
ORC
STIM
STIM
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Q1 24
-71.1%
Capex Intensity
ORC
ORC
STIM
STIM
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Q1 24
2.2%
Cash Conversion
ORC
ORC
STIM
STIM
Q4 25
1.16×
Q3 25
0.39×
Q2 25
Q1 25
1.51×
Q4 24
Q3 24
-0.86×
Q2 24
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons